This Month in the Journal  by Williamson, Robin E.
www.ajhg.org The American Journal of Human Genetics Volume 80 March 2007 i
THIS MONTH IN THE JOURNAL
Am. J. Hum. Genet. 2007;80:i–ii.  2007 by The American Society of Human Genetics. All rights reserved. 0002-9297/2007/8003-0001$15.00
DOI: 10.1086/512728
A SNP Can Neutralize Splicing Mutations, by
Nielsen et al. (p. 416)
There is increasing evidence that mutations can signiﬁ-
cantly affect splicing even when they are not located di-
rectly at the splice site. On this basis, Nielsen et al. ex-
amined the effects of a missense mutation within exon 5
on the expression of MCAD. The mutation was found pre-
viously in patients with medium-chain acyl-CoA dehy-
drogenase deﬁciency. Here, the mutation was shown to
decreasemRNA levels through a disruption of splicing that
led to skipping exon 5, early termination, and nonsense-
mediated decay. Through various minigene experiments,
the authors demonstrated that the mutation disrupted an
exonic splicing enhancer (ESE). They then went on tomea-
sure the effects of a second variant in exon 5, a synony-
mous polymorphism. This variant was predicted to alter
an exonic splicing silencer (ESS). Additional minigene ex-
periments revealed the complex interplay between these
two changes, and of splicing control in general, by dem-
onstrating that the introduction of the SNP disrupting the
ESS renders the transcript immune to the detrimental ef-
fects of the loss of the ESE.
Selection on ADH1B, by Han et al. (p. 441)
During alcohol metabolism, alcohol is broken down to
acetaldehyde by alcohol dehydrogenase, and the subse-
quent acetaldehyde is oxidized to acetate by acetaldehyde
dehydrogenase 2. The essential nature of these genes in
the body’s processing of alcohol has made them interest-
ing candidates in the search for variants associated with
alcohol dependence. One such association has been iden-
tiﬁed between a SNP in ADH1B and protection against
developing alcoholism. Because of the high frequency of
which this variant is found in East Asian populations,
there has been speculation that selection has occurred at
this locus. Han et al. decided to examine this hypothesis
by evaluating the selection signatures of SNPs across the
ADH region. Their results support the hypothesis that a
protective ADH1B haplotype underwent positive selection
in various populations from East Asia.
Phosphate Carrier Deﬁciency, by Mayr et al. (p.
478)
Disruptions of mitochondrial metabolism can cause a va-
riety of disorders with a wide range of severities. During
energy metabolism in mitochondria, adenosine diphos-
phate (ADP) is combined with inorganic phosphate to cre-
ate adenosine triphosphate (ATP). This inorganic phos-
phate is transported into the organelle by the mitochon-
drial phosphate carrier, PiC. Muscle-biopsy samples from
a pair of sisters presenting with cardiomyopathy andmus-
cle hypotonia revealed that, although the respiratory chain
was functioning normally, ATP synthesis was disrupted.
Because none of the genes known to be mutated in the
disruption of ATP synthesis were found to be affected, the
authors decided to check the PiC. A mutation was iden-
tiﬁed in an exon speciﬁc to the isoform expressed only in
heart and muscle. To further evaluate the effects of this
mutation, yeast deﬁcient for phosphate-carrier activity
were produced. The knockout yeast were able to grow only
on glucose. Those cells were then transformed with wild-
type human PiC as well as with the mutant human PiC.
Whereas the introduction of thewild-type protein enabled
growth on other types of media, the mutant protein did
not.
Gene-Expression Variation in Humans, by Storey et
al. (p. 502)
Sequence variation within and among populations has
been studied, but little is known about how gene-expres-
sion levels differ among humans. To examine this issue,
Storey et al. examined the expression patterns of 15,000
genes in eight CEPH individuals and in eight individuals
from Yoruba. The changes that they observed were small,
but 83% of the genes showed expression-level variation
among individuals, and the levels of 17% of the genes were
different between the two populations. It was also deter-
mined that most of the variation in expression levels for
speciﬁc genes was due to the component from differences
among individuals. A closer look at the pathways towhich
these genes belong suggested that the expression of genes
in the inﬂammatory pathway may signiﬁcantly differ
among populations. To evaluate the mechanisms behind
this variation, allelic expression was analyzed, and the dif-
ferential expression of the alleles suggested cis-regulation.
This Month on the Cover
In 1901, Landsteiner recognized that normal blood agglu-
tinized when mixed with serum. By analyzing which type
of serum led to the agglutination, he was able to categorize
blood into three groups: A, B, and C, which later became
known as “O” (Wienerklinische Wochenschrift 14:1132–
1134). His discovery was supplemented by that of von
Decastello and Sturli, in 1902, with their identiﬁcation of
a fourth group, which eventually became known as “AB”
(Munch Med Wsch 49:1090–1095). For a time, there was
a bit of confusion with the nomenclature when the blood
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groups were also identiﬁed and named independently by
Jansky in 1907 (Sborn Klincky 8:85–139) andMoss in 1910
(Bull Johns Hopk Hosp 21:63–70). Not only was the dis-
covery of the blood groups critical for effective and safe
blood transfusions, but blood type was also the ﬁrst trait
recognized to followMendelian inheritance, by Bernstein,
in 1925, when he suggested that the inheritance pattern
could best be explained by the presence of three alleles at
the blood-type locus (Z Induct Abstamm VererbLehre 37:
237–270). This ﬁnding identiﬁed the A, B, and O alleles
as the ﬁrst genetic markers to use in linkage-mapping stud-
ies. On the cover is a modern-day test for ABO typing. In
the top row, the blue solution contains antibodies against
the A antigen, and the yellow solution contains antibodies
against the B antigen. Blood of type A has been mixed
with each solution, and a precipitate has formed in the
blue solution as the antibodies bind the A antigens in the
blood. In contrast, no agglutination occurs in the yellow
solution, and a diffuse orange solution results. In the bot-
tom row, the reverse reaction is shown as a control. The
type A blood was mixed with type A cells (left) and type
B cells (right). Whereas no agglutination is observed on
the left, clumping is evident on the right as the anti-B
antibodies from the added blood bind the B antigens on
the type-B cells. Special thanks to Laura Kolaneci from the
blood bank at Brigham and Women’s Hospital in Boston
for her assistance with the photograph. Photograph by
Robin Williamson.
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